NCMS

We recently published a list of Top 8 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Nano-X Imaging Ltd. (NASDAQ:NNOX) stands against other top AI news updates investors should not miss.

Investigators employed artificial intelligence to characterize tissue samples of high-risk NMIBC that were likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG).

This review discusses the current state of multicancer early detection tests, the role of machine learning in their development, and their implications for oncology practice and patient care.

Medical errors are the third leading cause of death in the U.S., contributing to over 250,000 preventable deaths each year. NeuralCure AI is tackling this crisis head-on by eliminating diagnostic blind spots and accelerating treatment precision with its cutting-edge AI-driven decision support system.

One of the biggest hurdles in Medicare fraud detection is the extreme class imbalance, where fraudulent claims represent less than 1% of the total data. Traditional machine learning models tend to be biased toward the majority class,

The National Synchrotron Light Source II (NSLS-II)—a U.S. Department of Energy (DOE) Office of Science user facility at DOE's Brookhaven National Laboratory—is among the world's most advanced synchrotron light sources,

In this digital era, machine learning transforms cardiovascular disease (CVD) management by enhancing prediction accuracy, adapting to evolving medical data, and optimizing treatment. Vikas Nelamangala's research explores innovations in temporal data simulation and drift-resilient models,

SimCare AI, founded by two University of Chicago dropouts, has secured $2 million in seed funding to expand its AI-driven healthcare simulation platform. The company's solution uses realistic AI patients to set a new clinical benchmark, cutting training time and cost while meeting strict accreditation standards.